Uncoded by Premas Life Sciences Launches R&D Facility for Multi‑Omics
Uncoded, a unit of Premas Life Sciences, has launched a new R&D facility focused on multi‑omics—covering genomics, proteomics, transcriptomics, and metabolomics.
The facility aims to boost India’s capabilities in advanced life sciences, enabling faster research in diagnostics, disease tracking, and precision medicine. It provides scientists access to high-end tools and infrastructure for cutting-edge research.
The move supports India’s growing healthcare and biotech ecosystem. With this launch, Uncoded plans to accelerate scientific development and improve patient outcomes.
The company stated the center will help build a stronger life sciences platform in India and support innovations in personalized medicine.
This development aligns with India’s vision of becoming a global leader in biotech and scientific research.
Doctors, researchers, and healthcare startups are expected to benefit from access to this advanced facility, marking a major step forward in India’s biotech journey.
